NextCure, Inc. ( NXTC) - Key Metrics
NXTC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$2.80 | -$1.83 | -$1.83 |
| 2026Q1 | $0 | -$1.87 | -$2.55 | -$2.55 |
| 2025Q4 | $0 | -$2.69 | -$2.18 | -$2.18 |
| 2025Q3 | $0 | -$3.22 | -$2.34 | -$2.34 |
| 2025Q2 | $0 | -$11.29 | -$9.56 | -$9.56 |
NXTC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.14 |
| 2026Q1 | 0% | -1.43 |
| 2025Q4 | 0% | -1.32 |
| 2025Q3 | 0% | -0.45 |
| 2025Q2 | 0% | -0.12 |
NXTC
Price: $6.78
52 week price:
Earnings Per Share: -10.03 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 224200
Market Capitalization: 37.4 million